Search

everythinglearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Possible link between androgens and COVID-19 severity; more research needed.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Hair loss link to severe COVID-19 unclear.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Hair loss link to COVID-19 severity likely due to other factors.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Possible link between COVID-19 and hair loss; more research needed.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

COVID-19 can cause temporary hair loss due to stress and inflammation.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Some drugs may help treat both COVID-19 and radiation injury.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

COVID-19 may worsen hair loss, but treatments like minoxidil can help.